Stefano Baldoni, Dr

Department of Life, Hematology Section, Health and Environmental Sciences, University of L'Aquila, Italy

NA

Poster(s):

• 1007 - XPO1 mutations identify early stage CLL characterized by shorter time to first treatment and enhanced BCR signaling